| Serial Number | 97540674 |
| Word Mark | AMPERSAND |
| Filing Date | Tuesday, August 9, 2022 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, April 23, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 27, 2024 |
| Goods and Services | Biological therapeutics, namely, addressable and programmable protein-based therapeutics, including multi-specific polypeptide-based therapeutics, namely, therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders; pharmaceutical preparations, namely, addressable and programmable protein-based therapeutics, for treatment of genetic diseases and disorders, genomic diseases and disorders, hematological disorders, hormonal disorders, infectious diseases, reproductive disorders, metabolic disorders, orthopedic conditions, musculoskeletal diseases and disorders, gastrointestinal diseases and disorders, immune system-related diseases and disorders, dermatological diseases and disorders, cardiovascular diseases and disorders, neurological diseases and disorders, cancer, diabetes, and respiratory diseases and disorders |
| Goods and Services | Biological and chemical agents for scientific use other than for medical use, namely, addressable and programmable protein-based therapeutics |
| Goods and Services | Drug development services, namely, pharmaceutical drug development services; scientific research, namely, research and analysis services for the design and characterization of biologic therapeutic products, namely, pharmaceutical drug development services; pharmaceutical and biotech research and development, namely, pharmaceutical drug development services |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 19, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | Thursday, January 1, 1970 |
| First Use In Commerce Date | Thursday, January 1, 1970 |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, August 29, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | Thursday, January 1, 1970 |
| First Use In Commerce Date | Thursday, January 1, 1970 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, August 22, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, January 1, 1970 |
| First Use In Commerce Date | Thursday, January 1, 1970 |
| Party Name | AMPERSAND BIOTECHNOLOGIES, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, US 02125 |
| Party Name | AMPERSAND BIOTECHNOLOGIES, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, US 02125 |
| Party Name | Flagship Labs 75, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, US 02142 |
| Event Date | Event Description |
| Monday, August 29, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 26, 2023 | ASSIGNED TO EXAMINER |
| Saturday, May 27, 2023 | NON-FINAL ACTION WRITTEN |
| Saturday, May 27, 2023 | NON-FINAL ACTION E-MAILED |
| Saturday, May 27, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 22, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 22, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 23, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, October 4, 2023 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| Tuesday, October 24, 2023 | FINAL REFUSAL WRITTEN |
| Tuesday, October 24, 2023 | FINAL REFUSAL E-MAILED |
| Tuesday, October 24, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, January 18, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, January 18, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, January 18, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Thursday, January 18, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, January 18, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, January 19, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, January 20, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 7, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 7, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 27, 2024 | PUBLISHED FOR OPPOSITION |
| Monday, March 4, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 23, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |